
CEO, CTO Accused of Misleading Investors on COVID-19 Test
Parallax Health Sciences and the two executives settled charges related to claims the company made about a coronavirus screening test.
Parallax Health Sciences and the two executives settled charges related to claims the company made about a coronavirus screening test.
Amazon, Microsoft, and the gang are posting better returns and will keep on rising, says Barclays.
Equities helped boost the investment portfolio’s asset value by more than $60 billion to $254.8 billion.
Despite economic fallout from the pandemic, defined contribution plan balances remain strong.
The outlook for new technologies is bounteous, our symposium panel says.
The specter of higher capital gains taxes in 2022 accelerated activity, Echelon says.
Ohio SERS’s Majeed and NEBF’s Tarbox assess infrastructure, offices, retail, and more in our webinar.
Strong equity markets helped index outperform benchmark 60/40 index.